Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released May 1, 2018, after the close
10-Q filed May 1, 2018, 31 days after period end · 0001558370-18-003644
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Revenue | — | $3.58M | — | — |
| Net Income | -$24.39M | -$15.31M | — | — |
| EPS Diluted | -$0.17 | -$0.13 |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.19 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
